Switch To Branded denied for failing step therapy by Humana?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for switch to branded are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Switch To Branded
## Why Humana's Step Therapy Blocks the Branded Drug — and How to Override It
Step therapy protocols require that you try one or more preferred (typically generic or lower-cost) medications before Humana will approve the branded version. For a branded drug that has a generic equivalent, the step is usually the generic itself — Humana's position being that the generic should be tried first. A step-therapy denial means either (a) no trial of the required step is documented, or (b) the documentation submitted was not sufficient to satisfy the exception criteria.
## Why This Denial Is Appealable
Step-therapy protocols must include a medical exception pathway. Federal rules (and many state step-therapy override laws) require the plan to waive the step when the required medication was tried and failed, is contraindicated, is expected to cause adverse effects based on your medical history, or when the delay in starting the prescribed medication would result in irreversible harm or disease progression. Your prescriber's clinical judgment — backed by chart documentation — is the engine of a successful override.
Your federal and state appeal rights: - Step-therapy override request: Many states require plans to respond to an override request within specific timelines (often 72 hours for urgent cases). Ask Humana for the override process specific to your plan. - Internal appeal (ACA §2719 / ERISA §503): File within 180 days of the denial. The plan must address your clinical circumstances specifically. - External review: After internal exhaustion, an IRO applies objective clinical standards. The window is generally up to four months from final internal denial. - Expedited review (72 hours): Available when delay poses serious health risk.
## What to Gather
- Treatment history for the required step drug: If you tried the generic — dates started, dose range used, outcome, and reason for discontinuation. Adverse events should be documented in the chart, not just described in the appeal letter.
- Clinical reason for exception if not yet tried: If the generic is contraindicated or clinically inappropriate for you, the prescriber must explain why in writing, citing objective chart findings.
- Humana's step-therapy criteria: Request the current protocol for this drug. Note every step listed and every exception ground recognized.
- Prescriber override letter: Should address each step requirement directly — either confirming the step was completed or invoking a recognized exception ground with supporting documentation.
## Criteria-Mapping Structure
| Step Protocol Requirement | Patient History / Exception Ground | Evidence | |---|---|---| | Try generic/formulary alternative first | Tried [dates]; discontinued due to [outcome] | Chart note, adverse event record | | [If exception: contraindication or failure] | [Specific reason per chart] | Prescriber attestation + chart support | | [Additional step if listed] | [Completion or exception documented] | Corresponding record |
Your appeal letter should map the protocol step by step. If the step was completed, lead with the dates and outcome. If seeking an exception, quote the exception language from Humana's own policy and demonstrate that your facts meet it. External review is a strong fallback — IROs frequently overturn step-therapy denials when the override grounds are well-documented.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →